Literature DB >> 30604394

Supratentorial high-grade astrocytoma with leptomeningeal spread to the fourth ventricle: a lethal dissemination with dismal prognosis.

Mingxiao Li1, Xiaohui Ren1, Haihui Jiang1, Kaiyuan Yang1, Wei Huang1, Kefu Yu2, Hongyan Chen3, Gehong Dong4,5, Yong Cui1, Song Lin6,7.   

Abstract

PURPOSE: Leptomeningeal spread to the fourth ventricle (LSFV) from supratentorial high-grade astrocytoma (HGA) is rarely investigated. The incidence and prognostic merit of LSFV were analyzed in this study.
METHODS: A consecutive cohort of 175 patients with pathologically diagnosed HGA according to the 2016 WHO classification of brain tumors was enrolled. LSFV was defined as radiological occupation in the fourth ventricle at the moment of initial progression. Clinical, radiological, and pathological data were analyzed to explore the difference between HGA patients with and without LSFV.
RESULTS: There were 18 of 175 (10.3%) HGAs confirmed with LSFV. The difference of survival rate between patients with LSFV or not was significant in both overall survival (OS) (14.5 vs. 24 months, P =  0.0007) and post progression survival (PPS) (6.0 vs. 11.5 months, P = 0.0004), while no significant difference was observed in time to progression (TTP) (8.5 months vs. 9.5 months P = 0.6795). In the Cox multivariate analysis, LSFV was confirmed as an independent prognostic risk factor for OS (HR 2.06, P = 0.010). LSFV was correlated with younger age (P = 0.044), ventricle infringement of primary tumor (P < 0.001) and higher Ki-67 index (P = 0.013) in further analysis, and the latter two have been validated in the Logistic regression analysis (OR 18.16, P = 0.006; OR 4.04, P = 0.012, respectively).
CONCLUSION: LSFV was indicative of end-stage for supratentorial HGA patients, which shortened patients' PPS and OS instead of TTP. It's never too cautious to alert this lethal event when tumor harbored ventricle infringement and higher Ki-67 index in routine clinical course.

Entities:  

Keywords:  Dissemination; High-grade astrocytoma; Prognosis; The fourth ventricle

Mesh:

Substances:

Year:  2019        PMID: 30604394     DOI: 10.1007/s11060-018-03086-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  4 in total

1.  Classification of Progression Patterns in Glioblastoma: Analysis of Predictive Factors and Clinical Implications.

Authors:  Haihui Jiang; Kefu Yu; Mingxiao Li; Yong Cui; Xiaohui Ren; Chuanwei Yang; Xuzhe Zhao; Song Lin
Journal:  Front Oncol       Date:  2020-11-03       Impact factor: 6.244

2.  Efficacy of Whole-Ventricular Radiotherapy in Patients Undergoing Maximal Tumor Resection for Glioblastomas Involving the Ventricle.

Authors:  Kyung Hwan Kim; Jihwan Yoo; Nalee Kim; Ju Hyung Moon; Hwa Kyung Byun; Seok-Gu Kang; Jong Hee Chang; Hong In Yoon; Chang-Ok Suh
Journal:  Front Oncol       Date:  2021-09-21       Impact factor: 6.244

3.  T2/FLAIR Abnormity Could be the Sign of Glioblastoma Dissemination.

Authors:  Mingxiao Li; Wei Huang; Hongyan Chen; Haihui Jiang; Chuanwei Yang; Shaoping Shen; Yong Cui; Gehong Dong; Xiaohui Ren; Song Lin
Journal:  Front Neurol       Date:  2022-02-02       Impact factor: 4.003

4.  Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas.

Authors:  Mingxiao Li; Faliang Gao; Xiaohui Ren; Gehong Dong; Hongyan Chen; Alexander Y Lin; Daisy Dandan Wang; Mingyang Liu; Peter Ping Lin; Shaoping Shen; Haihui Jiang; Chuanwei Yang; Xiaokang Zhang; Xuzhe Zhao; Qinghui Zhu; Ming Li; Yong Cui; Song Lin
Journal:  Cancer Sci       Date:  2022-08-08       Impact factor: 6.518

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.